共 50 条
- [22] Orphan medicines: a success with a challenging future [J]. EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (03): : 185 - 187
- [24] Regulatory issues for orphan medicines: A review [J]. HEALTH POLICY AND TECHNOLOGY, 2020, 9 (01) : 115 - 121
- [25] LOW AVAILABILITY OF ORPHAN MEDICINES IN SERBIA [J]. VALUE IN HEALTH, 2013, 16 (03) : A123 - A124
- [26] THE AVAILABILITY AND EXPENDITURE OF ORPHAN MEDICINES IN POLAND [J]. VALUE IN HEALTH, 2015, 18 (03) : A304 - A304
- [28] Clinical trials of herbal medicines: Lessons learned and future priorities [J]. PLANTA MEDICA, 2014, 80 (16) : 1350 - 1350
- [29] Advancing innovative clinical trials to efficiently deliver medicines to patients [J]. Nature Reviews Drug Discovery, 2022, 21 : 543 - 544
- [30] Patient preferences for outcomes in clinical trials: implications for medicines optimization [J]. TRIALS, 2017, 18